Cargando…
Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions
BACKGROUND: Colorectal cancer is the second leading cause of cancer death in the United States, with over 50,000 deaths estimated in 2014. Molecular profiling for somatic mutations that predict absence of response to anti-EGFR therapy has become standard practice in the treatment of metastatic color...
Autores principales: | Brannon, A Rose, Vakiani, Efsevia, Sylvester, Brooke E, Scott, Sasinya N, McDermott, Gregory, Shah, Ronak H, Kania, Krishan, Viale, Agnes, Oschwald, Dayna M, Vacic, Vladimir, Emde, Anne-Katrin, Cercek, Andrea, Yaeger, Rona, Kemeny, Nancy E, Saltz, Leonard B, Shia, Jinru, D’Angelica, Michael I, Weiser, Martin R, Solit, David B, Berger, Michael F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189196/ https://www.ncbi.nlm.nih.gov/pubmed/25164765 http://dx.doi.org/10.1186/s13059-014-0454-7 |
Ejemplares similares
-
Targeted next-generation sequencing of colorectal cancer identified metastatic specific genetic alterations
por: Brannon, A Rose, et al.
Publicado: (2012) -
Local recurrences at the anastomotic area are clonally related to the primary tumor in sporadic colorectal carcinoma
por: Vakiani, Efsevia, et al.
Publicado: (2017) -
Contemporary Validation of a Nomogram Predicting Colon Cancer Recurrence, Revealing All-Stage Improved Outcomes
por: Konishi, Tsuyoshi, et al.
Publicado: (2019) -
Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma
por: Javier, Breanna M., et al.
Publicado: (2016) -
Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases
por: Shady, Waleed, et al.
Publicado: (2017)